Sigler M H, Teehan B P
Division of Nephrology, Lankenau Hospital, Philadelphia, Pennsylvania.
Kidney Int. 1987 Oct;32(4):562-71. doi: 10.1038/ki.1987.245.
A pumpless dialysis technique which combines continuous convection and diffusion was studied in 15 critically ill acute renal failure patients. Fluid identical in composition and purity to that used in peritoneal dialysis was continuously circulated (single-pass) at 16.6 cc/min through the dialysis compartment of a 0.43 m2 flat plate PAN membrane dialyzer. Whole blood clearances for urea, creatinine and phosphate averaged 25.3 +/- 4.4 cc/min, 24.1 +/- 5.5 cc/min and 21.3 +/- 5.6 cc/min, respectively. Over the range of blood flows studied (50 to 190 cc/min) clearances of these solutes were independent of blood flow rate but rather were determined by both dialysate flow rate and ultrafiltration rate. In contrast net fluxes of calcium and sodium were correlated only with ultrafiltration rate. Bicarbonate loss was 0.52 +/- 0.11 mEq/min; K+ balance varied with dialysate K+; glucose uptake from dialysate was 107 +/- 24.0 mg/min. In fresh non-clotting dialyzers, mean ultrafiltration rate was 8.1 cc/min. At QBi of 70 to 190 cc/min, dialysate and blood solute equilibrate yielding a total clearance equal to the dialysate outflow, or 25 cc/min, that is, the sum of dialysate flow rate plus ultrafiltration rate. In comparison to currently used continuous arteriovenous hemofiltration (CAVH), the exceptionally-high solute clearances obtained with continuous hemodialysis constitute a significant improvement in continuous renal replacement therapy.
对15例危重症急性肾衰竭患者研究了一种结合持续对流和扩散的无泵透析技术。将成分和纯度与腹膜透析所用液体相同的液体以16.6 cc/分钟的速度持续循环(单程)通过0.43平方米平板聚砜膜透析器的透析室。尿素、肌酐和磷酸盐的全血清除率平均分别为25.3±4.4 cc/分钟、24.1±5.5 cc/分钟和21.3±5.6 cc/分钟。在所研究的血流范围内(50至190 cc/分钟),这些溶质的清除率与血流速度无关,而是由透析液流速和超滤率共同决定。相比之下,钙和钠的净通量仅与超滤率相关。碳酸氢盐损失为0.52±0.11 mEq/分钟;钾平衡随透析液钾含量而变化;从透析液中摄取的葡萄糖为107±24.0 mg/分钟。在新鲜的无凝血透析器中,平均超滤率为8.1 cc/分钟。当血流量为70至190 cc/分钟时,透析液和血液中的溶质达到平衡,总清除率等于透析液流出量,即25 cc/分钟,也就是透析液流速与超滤率之和。与目前使用的持续动静脉血液滤过(CAVH)相比,持续血液透析获得的极高溶质清除率在持续肾脏替代治疗方面构成了显著改善。